SNWV
SANUWAVE Health, Inc. Common StockSNWV
SNWV
About: SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Employees: 46
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
288,512% more capital invested
Capital invested by funds: $30.7K [Q4 2024] → $88.5M (+$88.5M) [Q1 2025]
1,800% more funds holding
Funds holding: 1 [Q4 2024] → 19 (+18) [Q1 2025]
29.26% more ownership
Funds ownership: 0% [Q4 2024] → 29.26% (+29.26%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for SNWV.
Financial journalist opinion
Based on 4 articles about SNWV published over the past 30 days
Positive
Seeking Alpha
4 days ago
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
Sanuwave's UltraMIST offers superior wound care, reducing costs and healing time for hospitals, making it attractive to both providers and insurers. Under new CEO Morgan Frank, Sanuwave has revitalized growth, improved margins, and uplisted to Nasdaq, with the stock price quadrupling since his appointment. Revenue growth is robust, recurring consumables sales strengthen the business model, and the company is on track to triple manufacturing capacity.
Neutral
GlobeNewsWire
1 week ago
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the hiring of Dustin Libby as its EVP of commercial operations.
Neutral
GlobeNewsWire
2 weeks ago
Sanuwave Health Selected for Inclusion in Russell 2000® Index
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 2025 Russell indexes reconstitution, the Company's inclusion in the Russell 2000® Index.
Neutral
GlobeNewsWire
2 weeks ago
Sanuwave Health Appoints Greg Bazar to Board of Directors
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of Directors.
Neutral
Seeking Alpha
1 month ago
SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and CEO Peter Sorensen - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets Albert Hanser - Kestrel Christopher Davis - Founding Asset Management Ian Cassel - IFCM Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen-only mode.
Neutral
GlobeNewsWire
1 month ago
Sanuwave Announces Q1 FY2025 Financial Results
Q1 2025 revenues were $9.3 million , up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history.
Neutral
GlobeNewsWire
1 month ago
Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM (ET) to present its Q1 2025 financial results.
Neutral
GlobeNewsWire
2 months ago
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history.
Neutral
Seeking Alpha
2 months ago
SANUWAVE Health, Inc. (SNWV) Q4 2024 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q4 2024 Results Conference Call March 21, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and Chief Executive Officer Peter Sorensen - Chief Financial Officer Conference Call Participants Chris Plahm - Tall Pines Capital Carl Byrnes - Northland Capital Markets Ian Cassel - IFCM Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen-only mode.
Neutral
GlobeNewsWire
2 months ago
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
Q4 2024 revenues were $10.3 million, up 47% from Q4 2023. This was an all-time quarterly record for the Company.
Charts implemented using Lightweight Charts™